Rovera G M, DiMartini A, Schoen R E, Rakela J, Abu-Elmagd K, Graham T O
Division of Gastroenterology and Hepatology, Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania, USA.
Transplantation. 1998 Nov 15;66(9):1141-5. doi: 10.1097/00007890-199811150-00005.
Quality of life is an important consideration in evaluating new medical or surgical treatments. Intestinal transplantation is now available for patients with irreversible intestinal failure. We compared quality of life among patients with intestinal failure receiving home parenteral nutrition (HPN) to that among patients who underwent intestinal transplantation (ITx) at the University of Pittsburgh Medical Center.
The results of the Quality of Life Inventory, a self-administered questionnaire, were compared among 10 ITx recipients and 10 HPN patients. Change in quality of life was examined longitudinally over a 2-year period with repeat testing in four patients in each group.
ITx recipients were evaluated at mean time of 2.7 years after transplantation and after a mean period of 5.3 years of intestinal failure. HPN patients were evaluated after a mean period of 5.1 years of intestinal failure and were similar to the transplant recipients in age, gender, race, social status, education, etiology, and duration of disease. Assessed quality of life was markedly similar between HPN-dependent patients and ITx recipients, with significant differences in only 2 of 25 domains, despite the difficult early postoperative course and complex management that accompany intestinal transplantation. In longitudinal follow-up (n=4), ITx recipients reported significant improvement in anxiety (P=0.02), sleep (P=0.03), and impulsiveness/control (P<0.001), reflecting a progressive adjustment to their posttransplant status.
The quality of life in ITx recipients is similar to that in HPN-dependent patients. Quality of life among ITx recipients improves over time with decreased anxiety over physical functioning. Further research and efforts to improve quality of life in transplant recipients are needed.
生活质量是评估新的医学或外科治疗方法时的一个重要考量因素。目前,肠道移植可用于患有不可逆肠衰竭的患者。我们在匹兹堡大学医学中心比较了接受家庭肠外营养(HPN)的肠衰竭患者与接受肠道移植(ITx)的患者的生活质量。
对10名ITx受者和10名HPN患者进行了生活质量量表(一份自行填写的问卷)结果的比较。在两年时间内对每组中的4名患者进行重复测试,纵向观察生活质量的变化。
ITx受者在移植后平均2.7年且肠衰竭平均5.3年后接受评估。HPN患者在肠衰竭平均5.1年后接受评估,在年龄、性别、种族、社会地位、教育程度、病因和病程方面与移植受者相似。尽管肠道移植术后早期过程艰难且管理复杂,但依赖HPN的患者和ITx受者之间评估的生活质量明显相似,在25个领域中只有2个存在显著差异。在纵向随访(n = 4)中,ITx受者报告焦虑(P = 0.02)、睡眠(P = 0.03)和冲动性/自控力(P < 0.001)有显著改善,这反映出他们对移植后状态的逐渐适应。
ITx受者的生活质量与依赖HPN的患者相似。随着对身体功能焦虑的减轻,ITx受者的生活质量会随着时间推移而提高。需要进一步研究并努力改善移植受者的生活质量。